HATCH BIOFUND MANAGEMENT, LLC
HATCH BIOFUND MANAGEMENT, LLC is a Seed, Series A and early-stage fund in the US investing in therapeutics, vaccines, drug-discovery, biotechnology, small-molecules, cell-therapy and gene-therapy.
- Stages
- Seed, Series A, early-stage
- Sectors
- therapeutics, vaccines, drug-discovery, biotechnology, small-molecules, cell-therapy, gene-therapy
- Invests in
- US-wide
- Actively investing
- Yes
- Founded
- 2019
- Assets under management
- $50000000
- Website
- hatchbiofund.com
Check size not disclosed
Thesis
Hatch Biofund Management, LLC is a life sciences venture capital firm based in Doylestown, Pennsylvania, founded in 2019 and affiliated with the Pennsylvania Biotechnology Center. The firm's investment strategy focuses on early-stage private companies developing therapeutics and vaccines for human use, across various modalities including small molecules, cell therapy, and gene therapy. They prioritize companies with capital efficiency, well-understood disease biology, clear development pathways, and experimental medicines with significant societal value potential. Hatch Biofund primarily invests in seed and Series A funding rounds within the Drug Discovery and Biotechnology industries, having made at least nine investments to date. While specific AUM is not disclosed, the firm launched with a $50 million internal investment arm.
Common questions
Does HATCH BIOFUND MANAGEMENT, LLC invest at the Seed stage?
Yes. HATCH BIOFUND MANAGEMENT, LLC lists Seed, Series A and early-stage among the stages it invests in.
Where does HATCH BIOFUND MANAGEMENT, LLC invest?
HATCH BIOFUND MANAGEMENT, LLC invests in the US.